Hypofibrinogenemia caused by adrenocorticotropic hormone for infantile spasms: a case report

Atsushi Kamei1, Nami Araya1, Manami Akasaka1

  • 1Department of Pediatrics, Iwate Medical University School of Medicine, Morioka, Iwate, Japan.

Brain & Development
|April 17, 2014
PubMed

Insights

Adrenocorticotropic hormone (ACTH) therapy for infantile spasms can cause hypofibrinogenemia, a dangerous drop in fibrinogen levels. Monitor fibrinogen during ACTH treatment and stop if levels fall below 60.0 mg/dL.

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Pharmacology

Background:

  • Infantile spasms are a severe form of epilepsy in infants.
  • Adrenocorticotropic hormone (ACTH) therapy is a common treatment for infantile spasms.
  • Hypofibrinogenemia is a condition characterized by abnormally low levels of fibrinogen in the blood.

Observation:

  • A 7-month-old boy undergoing ACTH therapy for infantile spasms developed hypofibrinogenemia.
  • The patient's fibrinogen level dropped to 66.6 mg/dL, significantly below the reference range of 170-405 mg/dL.
  • No clinical signs of bleeding diathesis were observed in the patient.

Findings:

  • ACTH therapy can lead to a significant decrease in plasma fibrinogen levels.
  • Hypofibrinogenemia during ACTH therapy may occur even without overt bleeding.
  • Hemostatic levels of fibrinogen are considered to be above 60.0 mg/dL.

Implications:

  • Plasma fibrinogen levels should be routinely monitored in patients receiving ACTH therapy.
  • Discontinuation of ACTH therapy is recommended if fibrinogen levels fall below hemostatic levels or if bleeding tendencies arise.
  • This case highlights a potential adverse effect of ACTH therapy that requires clinical vigilance and monitoring.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15